Resources>Blog>Partner with Biointron: Your CRO Solution for Custom Antibody Development

Partner with Biointron: Your CRO Solution for Custom Antibody Development

Biointron 2024-12-12 Read time: 2 mins

The development of custom antibodies is a critical component in advancing research and therapeutic innovation. Biointron, a Contract Research Organization (CRO) specializing in antibody expression services, provides comprehensive support to biotech companies seeking reliable, scalable, and high-quality solutions for their antibody production needs.

Expertise in Antibody Discovery and Expression 

Biointron’s core strength lies in its expertise in the discovery, engineering, and expression of custom antibodies. The company employs advanced platforms for hybridoma development, phage display technology, and recombinant antibody expression to cater to a broad range of applications, including diagnostics, therapeutics, and basic research. 

One of Biointron’s key offerings is Abinvivo, a Biointron brand that provides in vivo antibodies and reagents for research use. Biointron’s catalog products for in vivo research can be found at Abinvivo, where we have a wide range of Benchmark Positive Antibodies, Isotype Negative Antibodies, Anti-Mouse Antibodies, Bispecific Antibodies, and Antibody-Drug Conjugates. 

Related: Abinvivo’s In Vivo Antibody Products: Differences in V3, V6, and V9

Abinvivo also integrates analytical validation as part of our services. This ensures that each batch of antibodies meets the purity, stability, and functional requirements critical for success in downstream applications. 

Supporting Therapeutic Antibody Development

The therapeutic antibody market continues to grow, driven by innovations in immuno-oncology, autoimmune disease therapies, and infectious disease research. Biointron supports these efforts by offering services like humanization of monoclonal antibodies, a key step in transitioning murine-derived antibodies for human clinical applications.

A Trusted Partner for Antibody R&D

Biointron is committed to maintaining transparent communication and collaboration throughout the project lifecycle. Our team of scientists works closely with clients to ensure the antibody development process aligns with project goals, budgets, and timelines.

For biotech firms navigating complex research demands, partnering with Biointron offers a streamlined approach to custom antibody development. Our integrated solutions, technical expertise, and focus on quality provide the support necessary to bring innovative antibody-based products to market.

Subscribe to our Blog
Recommended Articles
Roundup of Antibody Biotech Deals in January 2026

January 2026 deal activity leaned heavily toward bispecific, trispecific, and AD……

Feb 06, 2026
HEK293 vs CHO Cells for Antibody Expression: Mechanistic Differences, Product Quality, and Strategic Implications

This article examines HEK293 and CHO across biological characteristics, producti……

Jan 30, 2026
Antibody-Drug Conjugate (ADC) Programs to Watch in 2026

ADCs to watch in 2026. Clinical Trials, Primary Endpoints.

Jan 27, 2026
PepTalk 2026 – San Diego: Highlights and Event Recap

PepTalk 2026 highlights and event recap. Biotech antibody conference!

Jan 23, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.